JPRN-UMIN000030099
Not yet recruiting
未知
Prospective cohort study to examine exacerbation frequency and risk factors for joint symptoms related to postoperative endocrine treatment in breast cancer patients - Prospective cohort study on joint symptoms by postoperative endocrine treatment
Department of Breast and Endocrine Surgery, Okayama University Hospital0 sites300 target enrollmentJanuary 25, 2018
Conditionshormone-receptor-positive breast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hormone-receptor-positive breast cancer
- Sponsor
- Department of Breast and Endocrine Surgery, Okayama University Hospital
- Enrollment
- 300
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients judged inappropriate by doctors
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A prospective cohort study evaluating the occurrence of short and long-term cardiovascular complications in patients hospitalized with COVID-19cardiac abnormalitiescardiac complications1008220610014523NL-OMON52303niversitair Medisch Centrum Utrecht500
Active, not recruiting
Not Applicable
A Prospective Cohort Study Evaluating the Incidence of NephrogenicSystemic Fibrosis in Patients with Stages 3 to 5 Chronic Kidney DiseaseUndergoing MRI with the Injection of ProHance - Evaluation of the Incidence of NSF Following ProHance InjectioEUCTR2007-003589-16-FRBracco Imaging S.p.A.1,000
Not yet recruiting
Not Applicable
A prospective cohort study evaluating the incidence of and outcomes associated with dose reductions of diabetic medications in a population of older inpatients discharged to a nursing homeDiabetesACTRN12617000114347Flinders Medical Centre100
Completed
Not Applicable
Prospective Cohort Study to investigate factors affecting Health Related Quality of Life and the Effectiveness of Symptoms Monitoring via Computer-based Health Evaluation System (CHES) in Patients with Metastatic solid cancers during chemotherapyPatients with metastatic solid cancer (gastric cancer, colorectal cancer and breast cancer) scheduled for first line chemotherapy (including molecular targeted drug and immune checkpoint inhibitor)JPRN-UMIN000029663Kobe City Medical Center General Hospital115
Active, not recruiting
Not Applicable
Acute Heart Failure (AHF) Registry WürzburgISRCTN65006275niversity of Würzburg (Universitätsklinikum Würzburg) (Germany)1,000